Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7380 p737
17 December 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Study questions routine prophylaxis against thromboembolism after fracture below the knee

Fractures below the knee do not warrant routine prophylaxis against venous thromboembolism, concludes a Canadian prospective cohort study presented at the 47th annual meeting of the American Society of Hematology in Atlanta, Georgia, this week.

Between August 2002 and June 2005, 2,446 consecutive patients with fractures of the patella, fibula, foot and tibia were followed prospectively for three months, with thromboprophylaxis not allowed. Education regarding symptoms of deep vein thrombosis and pulmonary embolism was provided at study entry.

Presenting the results, Rita Selby, from the University of Toronto, said that by three months only seven of 1,174 patients (0.6 per cent) sustained a symptomatic, objectively confirmed venous thromboembolism.

“It is clear from these results that the side effects of thromboprophylaxis, such as gastrointestinal bleeds, outweigh any benefits and it is unlikely to be cost effective,” she said.

She added that many centres in Europe offer routine thromboprophylaxis for fractures below the knee and that the study should make them reconsider this practice. The study, however, does not have any implications for thromboprophylaxis after fractures above the knee, where the benefits outweigh risks.

The National Institute for Health and Clinical Excellence is expected to publish safety guidance on prophylaxis against venous thromboembolism in May 2007.

Back to Top


©The Pharmaceutical Journal